Analysts’ Downgrades for August, 12th (A, AROC, BSMX, CSFL, LGIH, LINC, LOXO, LXFR, MDLY, MG)

Analysts’ downgrades for Saturday, August 12th:

Agilent Technologies (NYSE:A) was downgraded by analysts at BidaskClub from a strong-buy rating to a buy rating.

Archrock (NYSE:AROC) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

Grupo Financiero Santander Mexico S.A. B. de C.V. (NYSE:BSMX) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.

CenterState Banks (NASDAQ:CSFL) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

LGI Homes (NASDAQ:LGIH) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “LGI Homes, Inc. is engaged in the design and construction of entry-level homes across Texas, Arizona, Florida and Georgia. The company focuses on converting renters of apartments and single-family homes into homeowners by offering homes at affordable locations. LGI Homes, Inc. is headquartered in The Woodlands, Texas. “

Lincoln Educational Services Corporation (NASDAQ:LINC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Lincoln Educational is a leading and diversified for-profit provider of a career-oriented post-secondary education headquartered in West Orange, New Jersey. It offers recent high school graduates and working adults degree and diploma programs in four principal areas of study: automotive technology, allied health (which includes programs for medical administrative assistants, medical assistants, pharmacy technicians and massage therapists), skilled trades and business and information technology. “

Loxo Oncology (NASDAQ:LOXO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut. “

Luxfer Holdings PLC (NYSE:LXFR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Luxfer Holdings PLC is a materials technology company specialising in the design, manufacture and supply of high-performance materials, components and gas cylinders. The company had two divisions, Elektron and Gas Cylinders. The Elektron division focuses on speciality materials based on magnesium, zirconium and rare earths. The Gas Cylinders division manufactures products made from aluminium, composites and other metals using technically advanced processes. Luxfer also offers recycling services and magnesium powders throughout global networks. It operates manufacturing plants in various countries, which include the United Kingdom, the United States, France, Czech Republic, Canada and China. Luxfer Holdings PLC is based in Salford, the United Kingdom. “

Medley Management (NYSE:MDLY) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.

Mistras Group (NYSE:MG) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Mistras Group, Inc. is a global provider of technology-enabled, non-destructive testing (NDT) solutions used to evaluate the structural integrity of critical energy, industrial and public infrastructure. The Company delivers a portfolio of solutions, ranging from routine NDT inspections to plant-wide asset integrity assessment and management solutions. The Company serves a global customer base, including companies in the oil and gas, fossil and nuclear power generation and transmission, public infrastructure, chemicals, aerospace and defense, transportation, primary metals and metalworking, pharmaceuticals and food processing industries. “

MakeMyTrip Limited (NASDAQ:MMYT) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “MakeMyTrip Limited is an online travel service company which offers travel products and solutions in India and the United States. The Company’s services and products include air tickets, customized holiday packages, hotel booking, railway tickets, bus tickets, car hire and facilitating access to travel insurance. MakeMyTrip Limited is the parent company of MakeMyTrip (India) Private Limited and MakeMyTrip.com Inc. Through its primary website, www.makemytrip.com, and other technology-enhanced platforms, the Company provides access to all major domestic full-service and low-cost airlines operating in India, all major airlines operating to and from India, a wide selection of hotels in and outside India, Indian Railways and several major Indian bus operators. MakeMyTrip Limited is based in Gurgaon, India. “

MannKind Corporation (NASDAQ:MNKD) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company’s lead product, the Technosphere Insulin System, consists of the Company’s dry-powder Technosphere formulation of insulin and the Company’s MedTone inhaler through which the powder is inhaled into the deep lung. “

MYOS RENS Technology (NASDAQ:MYOS) was downgraded by analysts at ValuEngine from a sell rating to a strong sell rating.

Semiconductor Manufacturing International Corporation (NYSE:SMI) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.

Carrols Restaurant Group (NASDAQ:TAST) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

USD Partners (NYSE:USDP) was downgraded by analysts at BidaskClub from a sell rating to a strong sell rating.

Vectrus (NYSE:VEC) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.

Zogenix (NASDAQ:ZGNX) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.